DigitasLBi Wins Five 2015 CLIO Awards
18 sept. 2015 10h49 HE
|
Digitas, Inc.
NEW YORK, Sept. 18, 2015 (GLOBE NEWSWIRE) -- DigitasLBi, a global marketing and technology company, today announces that it has won a total of five 2015 CLIO Awards. The company has been recognized...
AstraZeneca and Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial
24 août 2015 02h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Aug. 24, 2015 (GLOBE NEWSWIRE) -- AstraZeneca (NYSE:AZN) and Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing...
Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer
24 août 2014 21h16 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 24, 2014 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the appointment of pharmaceutical executive Mr Paul Hodgkinson as...
Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
10 juin 2013 02h10 HE
|
Pearl Therapeutics
Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics
Inc. today announced that it has entered into a definitive
merger agreement under which the Company will be acquired...
Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting
28 mars 2012 14h11 HE
|
Judicial Watch
WASHINGTON, DC--(Marketwire - Mar 28, 2012) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has uncovered documents...
SGLT2 Inhibitors a Promising New Therapy for Type II Diabetes: New Cutting Edge Information Report Analyzes Diabetes Market Forecast Through 2013
12 déc. 2008 08h12 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - December 12, 2008) - A new drug class is poised to
make a splash in the diabetes market, according to a new report, "Diabetes
Market Forecast to...